LifeVantage Q4 revenue up 6.4% to $54.2M; declares special $0.40 dividend; FY2024 EPS guide $0.52-0.62

Lifevantage Corp

2023-FY EPS reported $0.20 revenue$213,398,000

Q4 GAAP EPS $0.15 vs loss $0.11 YoY; adjusted EPS $0.17 vs $0.01; revenue $54.2M (+6.4% YoY).
Americas revenue +17.9% (U.S. +18.6%); APAC/Europe -16.0%; total active accounts fell 8.3% to 143K.
Declared special cash dividend of $0.40/share plus regular $0.035/share, payable Sep 22, 2023.
FY2024 guidance: revenue $216-226M, adjusted EBITDA $16-18M, adjusted EPS $0.52-0.62 (28% tax rate).
Strong balance sheet: $21.6M cash, no debt; FY2023 operating cash flow $6.8M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Lifevantage Corp reported fourth quarter ended June 30, 2023 results: revenue $54.2 million, net income $2.0 million, EPS $0.15 per diluted share.

Period: fourth quarter ended June 30, 2023
Revenue: $54.2 million
Net income: $2.0 million
EPS: $0.15 per diluted share
Result: reported results

Exact text from the filing

optimal health processes, today reported financial results for its fourth quarter and full fiscal year ended June 30, 2023. Fourth Quarter Fiscal 2023 Summary*: • Revenue of $54.2 million, an increase of 6.4% from the prior year period. Excluding the negative impact of foreign currency fluctuations, fourth quarter revenue was up approximately 7.8%; • Revenue in

View on SEC.gov

Browse all earnings releases →

Lifevantage Corp filing history →

Source: SEC EDGAR

accession 0000849146-23-000103

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.